(Press-News.org) DURHAM, NC – By tracking the very earliest days of one person's robust immune response to HIV, researchers have charted a new route for developing a long-sought vaccine that could boost the body's ability to neutralize the virus.
The research team, led by Barton F. Haynes, M.D., director of the Duke Human Vaccine Institute, and John Mascola, M.D., acting director of the NIH Vaccine Research Center, have for the first time described the co-evolution of antibodies and virus in a person with HIV whose immune system mounted a broad attack against the pathogen. Findings are published April 3, 2013, in the journal Nature.
Most vaccines work by inducing this antibody response, but the HIV virus has proved to be a difficult vaccine target. When HIV antibodies are produced, they typically have a limited range, and the virus changes rapidly to escape harm, leading to an arms race that the virus usually wins.
The current research was aided by new technologies that can detect early infection and track the subsequent immune response and virus evolution. It fills gaps in knowledge that have impeded development of an effective vaccine for a virus that has killed more than 30 million people worldwide.
"This project could only have been carried out by a multidisciplinary team working closely together," said Haynes, who led the work as a project of the Duke Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) consortium, which is funded by the National Institute of Allergy and Infectious Diseases. "For the first time, we have mapped not only the evolutionary pathway of the antibody, but also the evolutionary pathway of the virus, defining the sequence of events involved that induce the broadly neutralizing antibodies."
The key to this finding was a person in Africa whose HIV infection was detected so early that the virus had not yet mutated to avoid the immune assault. The individual also exhibited a fortuitous trait that occurs in only about 20 percent of people infected with HIV – an immune system that produces broadly neutralizing antibodies. These immune weapons attack vulnerable sites of the virus that are conserved despite mutations. In identifying the early viral infection, the team found the outer envelope, the viral surface glycoprotein, which triggered the start of the broadly neutralizing antibody development.
By tracking the precise virus and antibody pathways involved, the Duke CHAVI-ID and NIH teams now have a detailed road map for development of a potential vaccine, which involves immunogens with an outer envelope specifically selected to stimulate the production of broadly neutralizing antibodies.
"The next step is to use that information to make sequential viral envelopes and test them as experimental vaccines," Haynes said. "This is a process of discovery and we've come a long way with regard to understanding what the problem has been."
INFORMATION:
In addition to Haynes, study authors at Duke include lead author Hua-Xin Liao, plus Feng Gao, S. Munir Alam, Kevin Wiehe, Garnett Kelsoe, Guang Yang, Shi-Mao Xia, David C. Montefiori, Robert Parks, Krissey E. Lloyd, Richard M. Scearce, Kelly A. Soderberg, Yue Chen, Fangping Cai and Sheri Chen.
Additional authors include Rebecca Lynch, Tongqing Zhou, Jiang Zhu, Lawrence Shapiro, Mark K. Louder, Lillan M. Tran, Stephanie Moquin, Xiulian Du, M. Gordon Joyce, Sanjay Srivatsan, Baoshan Zhang, Anqi Zheng, Peter D. Kwong and John R. Mascola from the National Institute of Allergy and Infectious Diseases; Thomas B. Kepler from Boston University; Scott D. Boyd, Andrew Z. Fire and Krishna M. Roskin from Stanford University; Chaim A. Schramm and Zhenhai Zhang from Columbia University; James C. Mullikin and the NISC Comparative Sequencing Program at NIH; S. Gnanakaran, Peter Hraber and Bette T.M. Korber of Los Alamos National Laboratory; Myron Cohen of the University of North Carolina; Gift Kaminga of UNC Project, Malawi; George M. Shaw and Beatrice H. Hahn of the University of Pennsylvania.
The NIAID and National Institutes of Health provided funding for the research to the Center for HIV/AIDS Vaccine Immunology (AI067854) and the Center for Vaccine Immunology-Immunogen Discovery (AI100645).
Researchers find potential map to more effective HIV vaccine
2013-04-04
ELSE PRESS RELEASES FROM THIS DATE:
Thin clouds drove Greenland's record-breaking 2012 ice melt
2013-04-04
MADISON — If the sheet of ice covering Greenland were to melt in its entirety tomorrow, global sea levels would rise by 24 feet.
Three million cubic kilometers of ice won't wash into the ocean overnight, but researchers have been tracking increasing melt rates since at least 1979. Last summer, however, the melt was so large that similar events show up in ice core records only once every 150 years or so over the last four millennia.
"In July 2012, a historically rare period of extended surface melting raised questions about the frequency and extent of such events," says ...
Brain cell signal network genes linked to schizophrenia risk in families
2013-04-04
New genetic factors predisposing to schizophrenia have been uncovered in five families with several affected relatives. The psychiatric disorder can disrupt thinking, feeling, and acting, and blur the border between reality and imagination.
Dr. Debby W. Tsuang, professor of psychiatry and behavioral sciences, and Dr. Marshall S. Horwitz, professor of pathology, both at the University of Washington in Seattle, led the multi-institutional study. Tsuang is also a staff physician at the Puget Sound Veterans Administration Health Care System.
The results are published in ...
Satellite tagging maps the secret migration of white sharks
2013-04-04
Long-life batteries and satellite tagging have been used to fill in the blanks of female white sharks' (Carcharodon carcharias) lifestyles. Research published in the launch edition of BioMed Central's open access journal Animal Biotelemetry defines a two year migratory pattern in the Pacific Ocean. Pregnant females travel between the mating area at Guadalupe Island and nursery in Baja California, putting them and their young at risk from commercial fishing.
White sharks are pelagic much of their time, living in the open ocean. However they are also philopatric, in that ...
A fingerprint of exhaled breath
2013-04-04
Bodily fluids contain lots of information about the health status of a person. Medical doctors routinely have blood and urine analysed in order to obtain hints for infectious and metabolic diseases, to diagnose cancer and organ failure, and to check the dose of medication, based on compounds present in these body fluids. Researchers at ETH Zurich and at the University Hospital Zurich now propose to extend such analyses to breath, and in particular to take advantage of modern high-resolution analytical methods that can provide real-time information on the chemical composition ...
Baldness linked to increased risk of coronary heart disease
2013-04-04
Male pattern baldness is linked to an increased risk of coronary heart disease, but only if it's on the top/crown of the head, rather than at the front, finds an analysis of published evidence in the online journal BMJ Open.
A receding hairline is not linked to an increased risk, the analysis indicates.
The researchers trawled the Medline and the Cochrane Library databases for research published on male pattern baldness and coronary heart disease, and came up with 850 possible studies, published between 1950 and 2012.
But only six satisfied all the eligibility criteria ...
Low testosterone levels may herald rheumatoid arthritis in men
2013-04-04
Low testosterone levels may herald the subsequent development of rheumatoid arthritis in men, suggests research published online in the Annals of the Rheumatic Diseases.
Sex hormones are thought to play a part in the development of rheumatoid arthritis, and both men and women with the condition tend to have lower levels of testosterone in their blood than healthy people. But it is not clear whether this is a contributory factor or a consequence of the disease.
The researchers based their findings on participants of the Swedish Malmo Preventive Medicine Program (MPMP), ...
NIH scientists, grantees map possible path to an HIV vaccine
2013-04-04
In an advance for HIV vaccine research, scientists have for the first time determined how both the virus and a resulting strong antibody response co-evolved in one HIV-infected individual. The findings could help researchers identify which proteins to use in investigational vaccines to induce antibodies capable of preventing infection from an array of HIV strains. Previously, a study of antibody genetics enabled scientists to deduce the step-by-step evolution of certain broadly neutralizing antibodies—those that can prevent infection by the majority of HIV strains found ...
Shark tooth weapons reveal missing shark species in Central Pacific islands
2013-04-04
The Gilbert Island reefs in the Central Pacific were once home to two species of sharks not previously reported in historic records or contemporary studies. The species were discovered in a new analysis of weapons made from shark teeth and used by 19th century islanders, reported in a study published April 3 in the open access journal PLOS ONE by Joshua Drew from Columbia University and colleagues from the Field Museum of Natural History.
Sharks were culturally important to the Gilbertese Islanders; historic records indicate a complex ritual system surrounding shark fishing ...
NIH scientists develop monkey model to study novel coronavirus infection
2013-04-04
WHAT:
National Institutes of Health (NIH) researchers have developed a model of infection in rhesus macaques that will help scientists around the world better understand how an emerging coronavirus, first identified in September 2012, affects people. The virus has so far infected at least 17 people in the Middle East and Europe, killing 11 of them. The NIH team established the nonhuman primate model in December 2012 and is using it to study how the virus causes disease and to evaluate potential vaccines and antiviral treatments.
The model shows that clinical signs ...
Laser light zaps away cocaine addiction
2013-04-04
By stimulating one part of the brain with laser light, researchers at the National Institutes of Health (NIH) and the Ernest Gallo Clinic and Research Center at UC San Francisco (UCSF) have shown that they can wipe away addictive behavior in rats – or conversely turn non-addicted rats into compulsive cocaine seekers.
"When we turn on a laser light in the prelimbic region of the prefrontal cortex, the compulsive cocaine seeking is gone," said Antonello Bonci, MD, scientific director of the intramural research program at the NIH's National Institute of Drug Abuse (NIDA), ...